STX PHARMACEUTICALS ApS: Financial statements 2012
CVR: 25836812
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
STX PHARMACEUTICALS ApS (CVR 25836812) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -620,833 and a net result of DKK -498,287. Equity in the 2012 report amounted to DKK -4,287,693.
- Gross Profit
- DKK -620,833
- Profit/Loss
- DKK -498,287
- Equity
- DKK -4,287,693
- Total Assets
- DKK 140,262
Official annual report
Keep an eye on STX PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 21, 2012, Per Bendix Jeppesen has joined the board of directors of STX PHARMACEUTICALS ApS.
As of December 21, 2012, Per Bendix Jeppesen is registered as direktion of STX PHARMACEUTICALS ApS.
As of December 21, 2012, Katrine Steen is registered as chairman of STX PHARMACEUTICALS ApS.
As of December 21, 2012, Niels Vesth has stepped down as adm. dir of STX PHARMACEUTICALS ApS.
As of November 21, 2012, Ole Bitsch-Jensen has stepped down as chairman of STX PHARMACEUTICALS ApS.
About STX PHARMACEUTICALS ApS
STX PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company has been dissolved on 16 March 2015. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2006). In 2012, the company reported a gross profit of DKK -620,833 and a net result of DKK -498,287. Equity in the 2012 report amounted to DKK -4,287,693.